328 related articles for article (PubMed ID: 22989537)
1. Primary hyperparathyroidism in children and adolescents.
Roizen J; Levine MA
J Chin Med Assoc; 2012 Sep; 75(9):425-34. PubMed ID: 22989537
[TBL] [Abstract][Full Text] [Related]
2. A novel mutation of the calcium-sensing receptor gene in a German subject with familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
Papadakis M; Meurer N; Margariti T; Meyer A; Weyerbrock N; Dotzenrath C
Hormones (Athens); 2016 Oct; 15(4):557-559. PubMed ID: 28222409
[TBL] [Abstract][Full Text] [Related]
3. Calcium-sensing-related gene mutations in hypercalcaemic hypocalciuric patients as differential diagnosis from primary hyperparathyroidism: detection of two novel inactivating mutations in an Italian population.
Stratta P; Merlotti G; Musetti C; Quaglia M; Pagani A; Izzo C; Radin E; Airoldi A; Baorda F; Palladino T; Leone MP; Guarnieri V
Nephrol Dial Transplant; 2014 Oct; 29(10):1902-9. PubMed ID: 25104082
[TBL] [Abstract][Full Text] [Related]
4. Familial Hypocalciuric Hypercalcemia as an Atypical Form of Primary Hyperparathyroidism.
Marx SJ
J Bone Miner Res; 2018 Jan; 33(1):27-31. PubMed ID: 29115694
[TBL] [Abstract][Full Text] [Related]
5. A homozygous inactivating calcium-sensing receptor mutation, Pro339Thr, is associated with isolated primary hyperparathyroidism: correlation between location of mutations and severity of hypercalcaemia.
Hannan FM; Nesbit MA; Christie PT; Lissens W; Van der Schueren B; Bex M; Bouillon R; Thakker RV
Clin Endocrinol (Oxf); 2010 Dec; 73(6):715-22. PubMed ID: 20846291
[TBL] [Abstract][Full Text] [Related]
6. Familial Hypocalciuric Hypercalcemia Types 1 and 3 and Primary Hyperparathyroidism: Similarities and Differences.
Vargas-Poussou R; Mansour-Hendili L; Baron S; Bertocchio JP; Travers C; Simian C; Treard C; Baudouin V; Beltran S; Broux F; Camard O; Cloarec S; Cormier C; Debussche X; Dubosclard E; Eid C; Haymann JP; Kiando SR; Kuhn JM; Lefort G; Linglart A; Lucas-Pouliquen B; Macher MA; Maruani G; Ouzounian S; Polak M; Requeda E; Robier D; Silve C; Souberbielle JC; Tack I; Vezzosi D; Jeunemaitre X; Houillier P
J Clin Endocrinol Metab; 2016 May; 101(5):2185-95. PubMed ID: 26963950
[TBL] [Abstract][Full Text] [Related]
7. Case Report: Severe Neonatal Course in Paternally Derived Familial Hypocalciuric Hypercalcemia.
Höppner J; Lais S; Roll C; Wegener-Panzer A; Wieczorek D; Högler W; Grasemann C
Front Endocrinol (Lausanne); 2021; 12():700612. PubMed ID: 34659108
[TBL] [Abstract][Full Text] [Related]
8. Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Rejnmark L; Brixen K; Mosekilde L
Eur J Endocrinol; 2008 Dec; 159(6):719-27. PubMed ID: 18787045
[TBL] [Abstract][Full Text] [Related]
9. Calcium-sensing receptor (CASR) mutations in hypercalcemic states: studies from a single endocrine clinic over three years.
Guarnieri V; Canaff L; Yun FH; Scillitani A; Battista C; Muscarella LA; Wong BY; Notarangelo A; D'Agruma L; Sacco M; Cole DE; Hendy GN
J Clin Endocrinol Metab; 2010 Apr; 95(4):1819-29. PubMed ID: 20164288
[TBL] [Abstract][Full Text] [Related]
10. A novel CASR mutation associated with neonatal severe hyperparathyroidism transmitted as an autosomal recessive disorder.
Diaz-Thomas A; Cannon J; Iyer P; Al-Maawali A; Fazalullah M; Diamond F; Mueller OT; Root AW; Alyaarubi S
J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):851-6. PubMed ID: 24854525
[TBL] [Abstract][Full Text] [Related]
11. Familial hypocalciuric hypercalcemia and related disorders.
Lee JY; Shoback DM
Best Pract Res Clin Endocrinol Metab; 2018 Oct; 32(5):609-619. PubMed ID: 30449544
[TBL] [Abstract][Full Text] [Related]
12. A case of familial hypocalciuric hypercalcemia type 1 due to CASR p.Pro55Leu mutation.
Sumida A; Iizuka K; Kato T; Liu Y; Kubota S; Kubota-Okamoto S; Sakurai T; Imaizumi T; Takahashi Y; Mizuno M; Takao K; Hirota T; Suwa T; Horikawa Y; Yamamoto M; Seino Y; Suzuki A; Yabe D
BMC Endocr Disord; 2022 Jun; 22(1):164. PubMed ID: 35733207
[TBL] [Abstract][Full Text] [Related]
13. Subtotal Parathyroidectomy Successfully Controls Calcium Levels of Patients with Neonatal Severe Hyperparathyroidism Carrying a Novel CASR Mutation.
Wejaphikul K; Dejkhamron P; Khorana J; Watcharachan K; Intachai W; Olsen B; Tongsima S; Ketudat Cairns JR; Ngamphiw C; Kantaputra P
Horm Res Paediatr; 2023; 96(4):432-438. PubMed ID: 36626889
[TBL] [Abstract][Full Text] [Related]
14. New mutation in the CASR gene in a family with familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism (NSHPT).
Rodrigues LS; Cáu AC; Bussmann LZ; Bastida G; Brunetto OH; Corrêa PH; Martin RM
Arq Bras Endocrinol Metabol; 2011 Feb; 55(1):67-71. PubMed ID: 21468522
[TBL] [Abstract][Full Text] [Related]
15. Forearm bone mineral density in familial hypocalciuric hypercalcemia and primary hyperparathyroidism: a comparative study.
Isaksen T; Nielsen CS; Christensen SE; Nissen PH; Heickendorff L; Mosekilde L
Calcif Tissue Int; 2011 Oct; 89(4):285-94. PubMed ID: 21785908
[TBL] [Abstract][Full Text] [Related]
16. Primary hyperparathyroidism and familial hypocalciuric hypercalcemia: relationships and clinical implications.
Eldeiry LS; Ruan DT; Brown EM; Gaglia JL; Garber JR
Endocr Pract; 2012; 18(3):412-7. PubMed ID: 22232026
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid hormone-dependent familial hypercalcemia with low measured PTH levels and a presumptive novel pathogenic mutation in CaSR.
Mahajan A; Buse J; Kline G
Osteoporos Int; 2020 Jan; 31(1):203-207. PubMed ID: 31641801
[TBL] [Abstract][Full Text] [Related]
18. Familial Hyperparathyroidism - Disorders of Growth and Secretion in Hormone-Secretory Tissue.
Marx SJ; Lourenço DM
Horm Metab Res; 2017 Nov; 49(11):805-815. PubMed ID: 29136674
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology, Pathophysiology, and Genetics of Primary Hyperparathyroidism.
Minisola S; Arnold A; Belaya Z; Brandi ML; Clarke BL; Hannan FM; Hofbauer LC; Insogna KL; Lacroix A; Liberman U; Palermo A; Pepe J; Rizzoli R; Wermers R; Thakker RV
J Bone Miner Res; 2022 Nov; 37(11):2315-2329. PubMed ID: 36245271
[TBL] [Abstract][Full Text] [Related]
20. A Case of a Heterozygous Inactivating CASR Variant with Adult-Onset Symptomatic Hypercalcemia Requiring Extensive Surgery.
Veldeman L; Robbrecht S; Breckpot J; Weynand B; Decallonne B
Calcif Tissue Int; 2020 Jul; 107(1):104-108. PubMed ID: 32306059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
